Novavax Stock Rallies 15% Following Bullish Jefferies Note
Jefferies Maintains Novavax(NVAX.US) With Buy Rating, Maintains Target Price $31
Jefferies Sticks to Their Buy Rating for Novavax (NVAX)
Looking Into Novavax's Recent Short Interest
World Organization For Animal Health Says Germany Reports Outbreak Of Highly Pathogenic H5N1 Bird Flu On Farm In Eastern Part Of The Country
U.S. stock market anomaly | novavax (NVAX.US) fell by 7%, with a volume exceeding 5.53 million.
As of the publication deadline, the stock fell by 7%, closing at $12.37.